Ironwood Pharmaceuticals, Inc. · NASDAQ:IRWD
Silber Jeffrey received 137,036 Ironwood Pharmaceuticals, Inc. shares as an award (Form 4)
Traded Jul 20, 2026 · Filed Jul 22, 2026
On Jul 20, 2026, Silber Jeffrey (SVP, CMO, Head-Res&Drug) received 137,036 Ironwood Pharmaceuticals, Inc. shares as an award, leaving 137,036 shares. Filed Jul 22, 2026 (Form 4).
- Awarded
- 137,036 shares
- Holding after
- 137,036 shares
- Trading plan
- No
- Role
- SVP, CMO, Head-Res&Drug
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jul 20, 2026 | Class A Common Stock | Award | 137,036 | 137,036 | Direct |
Source
Related
- Ironwood Pharmaceuticals, Inc.
- Silber Jeffrey
- Ironwood Pharmaceuticals, Inc. shareholders
- Form 4 · Denner Alexander J · Sep 17, 2026
- Schedule 13G/A · Armistice Capital, LLC · Aug 14, 2026
- Schedule 13G · State Street Corp · Aug 7, 2026
- Schedule 13G/A · BlackRock, Inc. · Jul 28, 2026
- Form 4 · Silver Ronald · Jul 9, 2026